IBD 50 Stock Doximity Rockets And Eyes A Breakout After Walloping Earnings Views
Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook for the ...
Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Glamour on MSN5 天
Of Course Hailey Bieber Is Giving Diaper Bags an Olsen-Approved Update
However, when you buy something through our retail links, Condé Nast may earn an affiliate commission.Hailey Bieber may be a mom on the go, but that doesn't mean she needs to sacrifice style in the ...
Gear Patrol on MSN6 天
The Best New Gadgets and Hi-Fi Releases of 2025 (Updated)
TAD, or Technical Audio Devices, is a Japanese hi-fi maker known for its extremely high-end and expensive loudspeakers. To date, its smallest and most affordable speakers, the boo ...